Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Pyrvinium pamoate [USP:INN:BAN:JAN]
RN: 3546-41-6
UNII: 310X6S84LW
InChIKey: OOPDAHSJBRZRPH-UHFFFAOYSA-N

Classification Codes

  • Anthelmintic
  • Drug / Therapeutic Agent
  • Mutation Data

Molecular Formulas

  • C26-H28-N3.1/2C23-H14-O6
  • C75-H70-N6-O6

Molecular Weight

  • 1153.4298
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Pyrvinium pamoate
  • Pyrvinium pamoate [USP:INN:BAN:JAN]

Synonyms

  • 6-(Dimethylamino)-2-(2-(2,5-dimethyl-1-phenylpyrrol-3-yl)vinyl)-1-methylquinolinium 4,4'-methylenebis(3-hydroxy-2-naphthoate) (2:1)
  • AI3-27252
  • Alnoxin
  • Altolat
  • CCRIS 3438
  • EINECS 222-596-3
  • Embonate de pyrvinium
  • Molevac
  • Neo-oxypate
  • Neooxypaat
  • NSC 223622
  • Pamovin
  • Pirvinio pamoato
  • Pirvinio pamoato [DCIT]
  • Pirvinium pamoate
  • Povan
  • Povanyl
  • Pyrcon
  • Pyrvinium 4,4'-methylenebis(3-hydroxynaphthalene-2-carboxylate)
  • Pyrvinium embonate
  • Pyrvinium pamoate
  • Quinolinium, 6-(dimethylamino)-2-(2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl)-1-methyl-, salt with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (2:1)
  • SN-4395
  • Tolapin
  • TRU
  • UNII-310X6S84LW
  • Vanquin
  • Viprynium embonate

Systematic Names

  • Pyrvinium embonate
  • Pyrvinium pamoate
  • Quinolinium, 6-(dimethylamino)-2-(2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl)-1-methyl-, salt with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (2:1)
  • Quinolinium, 6-(dimethylamino)-2-(2-(2,5-dimethyl-1-phenylpyrrol-3-yl)vinyl)-1-methyl-, salt with 4,4'-methylenebis(3-hydroxy-2-naphthoic acid) (2:1)

Registry Numbers

CAS Registry Number

  • 3546-41-6

FDA UNII

  • 310X6S84LW

Related Registry Number

  • 7187-62-4 (Parent)

System Generated Number

  • 0003546416

Molecular Formulas

Molecular Formulas

  • C26-H28-N3.1/2C23-H14-O6
  • C75-H70-N6-O6

Molecular Formula Fragments

  • C23-H14-O6
  • C26-H28-N3
  • COMPONENT

Structure Descriptors

InChI

1S/2C26H28N3.C23H16O6/c2*1-19-17-21(20(2)29(19)24-9-7-6-8-10-24)11-13-23-14-12-22-18-25(27(3)4)15-16-26(22)28(23)5;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h2*6-18H,1-5H3;1-10,24-25H,11H2,(H,26,27)(H,28,29)/q2*+1;

InChIKey

OOPDAHSJBRZRPH-UHFFFAOYSA-N

Smiles

CN(C)c1ccc2c(ccc(\C=C\c3cc(C)n(c3C)c4ccccc4)[n+]2C)c1.CN(C)c5ccc6c(ccc(\C=C\c7cc(C)n(c7C)c8ccccc8)[n+]6C)c5.OC(=O)c9cc%10ccccc%10c(Cc%11c(O)c(cc%12ccccc%11%12)C(=O)O)c9O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 subcutaneous 200mg/kg (200mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: TREMOR
Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 1349, 1965.
mouse LDLo intraperitoneal 5mg/kg (5mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 5, Pg. 305, 1971.